Search - tctmd.com

Displaying 561 - 580 of 3009

Sort: Relevancy | Date

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Shelley Wood

November 10, 2022

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Todd Neale

November 10, 2022

News Conference News AHA 2022

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Yael L. Maxwell

November 10, 2022

Presentation AHA 2022

Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial

Presenter: Michelle L. O’Donoghue

November 07, 2022

Presentation AHA 2022

Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease

Presenter: Pamela S. Douglas

November 07, 2022

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

Shelley Wood

November 06, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

Presentation Cardiovascular Interventions 2022

Do All Patients with New Onset HF Need Assessment for CAD?

Presenter: J. Thomas Heywood

October 28, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

News Conference News EACTS 2022

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

Michael O'Riordan

October 12, 2022

News Daily News

Guideline Guidance: Practical Tips for Finding, Triaging Chest Pain in the ED

Yael L. Maxwell

October 12, 2022

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Daily News

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

Caitlin E. Cox

October 11, 2022

News Conference News EACTS 2022

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Michael O'Riordan

October 07, 2022

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Caitlin E. Cox

October 03, 2022

Advertisement

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial

Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Do All Patients with New Onset HF Need Assessment for CAD?

New Biomarker-Based Risk Score Performs Well in ACS

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

Guideline Guidance: Practical Tips for Finding, Triaging Chest Pain in the ED

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content